Development of a gene expression database and related analysis programs for evaluation of anticancer compounds

Area of Science:

• Pharmacogenomics
• Cancer Biology
• Bioinformatics

Background:

• Genome-wide transcriptional expression analysis is crucial for understanding anticancer compound activity.
• Existing resources lack a comprehensive, user-friendly, public database for anticancer agent gene expression.

Purpose of the Study:

• To develop a public gene expression database specifically for anticancer agents.
• To create associated analysis tools for easier interpretation of drug effects.

Main Methods:

• Examined gene expression profiles in human cancer cells exposed to 35 anticancer compounds.
• Extracted gene signatures (up/downregulated genes) and performed hierarchical clustering and Connectivity Map analysis.
• Developed analysis programs for gene expression scoring and pathway analysis (Kyoto Encyclopedia of Genes and Genomes).

Main Results:

• Gene expression profiles revealed drug-specific signatures.
• Hierarchical clustering grouped drugs by mechanism of action (e.g., genotoxic drugs).
• Connectivity Map analysis confirmed reflection of drug modes of action.
• Demonstrated selective classification of proteasome inhibitors as endoplasmic reticulum stress inducers.

Conclusions:

• The developed public database and analysis tools provide an efficient system for evaluating novel compound mechanisms of action.
• This resource facilitates the identification of promising anticancer lead compounds.
• The system successfully classified proteasome inhibitors, highlighting its utility.